Sarepta Therapeutics
SRPT
#1549
Rank
โ‚น964.82 B
Marketcap
โ‚น10,101
Share price
-1.03%
Change (1 day)
0.38%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2024 (TTM): โ‚น10.79 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are โ‚น1.64 Billion. In 2023 the company made an earning of -โ‚น44.99 Billion, an increase over its 2022 earnings that were of -โ‚น59.68 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น10.79 B-124%
2023 -โ‚น44.99 Billion-24.62%
2022 -โ‚น59.68 Billion64.69%
2021 -โ‚น36.24 Billion-24.25%
2020 -โ‚น47.84 Billion-22.53%
2019 -โ‚น61.75 Billion96.87%
2018 -โ‚น31.37 Billion645.68%
2017 -โ‚น4.21 Billion-81.81%
2016 -โ‚น23.12 Billion21.47%
2015 -โ‚น19.03 Billion62.04%
2014 -โ‚น11.75 Billion21.26%
2013 -โ‚น9.69 Billion60.93%
2012 -โ‚น6.02 Billion93.69%
2011 -โ‚น3.11 Billion71.58%
2010 -โ‚น1.82 Billion35.06%
2009 -โ‚น1.35 Billion-11.62%
2008 -โ‚น1.52 Billion-47.02%
2007 -โ‚น2.87 Billion0.38%
2006 -โ‚น2.86 Billion88.3%
2005 -โ‚น1.52 Billion-30.06%
2004 -โ‚น2.17 Billion32.69%
2003 -โ‚น1.64 Billion-25.52%
2002 -โ‚น2.2 Billion64.52%
2001 -โ‚น1.34 Billion50.4%
2000 -โ‚น0.89 Billion26.44%
1999 -โ‚น0.71 Billion8%
1998 -โ‚น0.65 Billion102.7%
1997 -โ‚น0.33 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น15.22 B 36.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น22.76 Billion-303.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น24.26 Billion-316.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น10.74 Billion-195.92%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น16.17 Billion-244.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น36.8 Billion-428.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น67.51 Billion-703.21%๐Ÿ‡บ๐Ÿ‡ธ USA